Valitor, Inc. is a biotechnology company founded to develop advanced, protein-based drugs. Using our core technology, we can modify existing biological therapies to achieve substantial control over their pharmacological properties. We have initiated a pipeline of drug products that will be used to treat a variety of diseases currently imposing a significant financial burden on the nationÕs healthcare system. Our mission is to develop a new generation of biologic therapies that will reduce the costs associated with effective treatment of these diseases. We also aim to improve the patientsÕ quality of life by reducing the required frequency of therapeutic administration.